Title

'New Kids on the Block' in Chronic Kidney Disease

Document Type

Presentation

Department

Nephrology

Abstract

Sodium-Glucose Cotransporter 2 Inhibitors: Role in Renal Disease, Dr. Chao-Yu Hsu. Overview:

  • History
  • Mechanism of Action
  • Use in diabetic kidney disease
  • Beyond diabetic kidney disease
  • Considerations and limitations

GLP-1 Receptors Agonists use in Diabetic Kidney Disease, Dr. Ana Molovic-Kokovic

Finerenone: A Third Generation Mineralocorticoid Receptor Antagonist, Dr. Steve Silver

To Recap, Dr. Marvin Grieff

  • SGLT2 inhibitors
  • GLP-1 agonists
  • Finerenone

Publication Date

3-3-2022

Comments

00:02:27 Sodium-Glucose Cotransporter 2 Inhibitors: Role in Renal Disease

00:17:12 GLP-1 Receptors Agonists use in Diabetic Kidney Disease

00:38:05 Finerenone: A Third Generation Mineralocorticoid Receptor Antagonist

00:54:10 To Recap

Loading...

Media is loading
 

This document is currently not available here.

Share

COinS